<p>Vaccines are a key part of a long-term strategy to bring SARS-CoV-2 under control. It is essential to roll out vaccination rapidly to protect as many people as possible and to lower the opportunities for the virus to evolve further. Any vaccine must be authorised by the European Medicines Agency (EMA).</p>

<p>The European Commission has secured up to 4.4 billion doses of COVID-19 vaccines so far - and negotiations are underway for additional doses. However, countries are facing different challenges around the disinformation or vaccine acceptance. The European Parliament is trying to keep an eye on the purchase and safety of these vaccines. During June plenary the EP adopted a resolution calling for COVID-19 vaccine patent waiver. Parliament proposed negotiations start for a temporary waiver of the WTO TRIPS Agreement on patents to improve global access to affordable COVID-19-related medical products and to address global production constraints and supply shortages. The EP approved also the Digital Green Certificate to facilitate the safe free movement of citizens within the EU during the pandemic.</p>

Committee on Environment, Public Health and Food Safety

healthcare safety (T)

European Medicines Agency

9th parliamentary term

Coronavirus outbreak (T)

EU4Health Programme 2021-2027 (T)

vaccination strategy (T)

EU Vaccine Strategy

Announcement of the results of the voting session (09/06): final votes on the conflict of interest of the Czech Prime Minister, and the agreement on Covid-19 vaccines and others

EU Vaccines strategy: extracts from the debate

Exchange of views with Ngozi OKONJO-IWEALA, Director-General of the World Trade Organization (WTO) at EP Committee on International Trade: extracts

Waiver of the Global Covid 19 vaccines patents: extracts from the debate

Statement by Chrysoula ZACHAROPOULOU (Renew, FR), co-Chair of the COVAX Council: statement and meeting with David SASSOLI, EP President

The European Union Health Union package and the WHO’s global response to the pandemic: opening, presentation and exchange of views with the World Health Organization (recorded)

ENVI Committee -  Exchange of views with the World Health Organization on the European Union Health Union package and the WHOâs global response to the pandemic

Updates on the EU response to the Covid-19 pandemic: Exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety - ENVI Committee

Exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety, in ENVI Committee: Questions and answers

Exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety, in ENVI Committee: Opening remark by Pascal CANFIN (Renew, FR), ENVI Chair and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

ENVI Committee -  Exchange of views with Stella KYRIAKIDES, Commissioner for Health and Food Safety.

Quicker authorization procedure for adapted COVID-19 vaccines: exchange of views and statement by Cristian-Silviu BUŞOI (EPP, RO), Chair of the EP Committee on Industry, Research and Energy

EP Plenary session  - EU transparency in the development, purchase and distribution of COVID-19 vaccines

EP Plenary session - EU transparency in the development, purchase and distribution of COVID-19 vaccines

Committee on the Environment, Public Health and Food Safety

ENVI

Committee on Budgetary Control

CONT

ENVI - ITRE  Joint meeting

ITRE

Committee on Budgets

BUDG

EU transparency in the development, purchase and distribution of COVID-19 vaccines - O.Q. to Commission: MEPs debate

EU transparency in the development, purchase and distribution of COVID-19 vaccines - O.Q. to Commission: opening statements by Dolors MONTSERRAT (EPP, ES), Author and by Ylva JOHANSSON, European Commissioner for Home Affairs

EU transparency in the development, purchase and distribution of COVID-19 vaccines - O.Q. to Commission: closing statement by Ylva JOHANSSON, European Commissioner for Home Affairs

Infoclip: Health crisis

Preparation of the G7 Summit: extracts from the debate

Announcement of the results of the voting session (08/06) notably on the EU Digital COVID Certificate and ambiance shots prior to the debate

Infoclip: EU Digital COVID Certificate (posed scenes - updated version)

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 3/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Closing statements by Council and Comission

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 1/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: MEPs debate part 2/3

Meeting the Global COVID-19 challenge: effects of waiver of the WTO TRIPS agreement on COVID-19 vaccines, treatment, equipment and manufacturing capacity in developing countries: Opening statements Council and Commission

Trilogue on the EU COVID-19 certificate: arrivals, roundtable and statement by Juan Fernando LÓPEZ AGUILAR (S&D, ES), Rapporteur and by Didier REYNDERS, European Commissioner for Justice

Joint debate on the Digital green certificate - Union citizens & third countries - The accessibility and affordability of Covid-testing: opening statements by Ana Paula ZACARIAS and Didier REYNDERS

Joint debate on the Digital green certificate - Union citizens & third countries - The accessibility and affordability of Covid-testing: MEPs debate part 1/3

Joint debate on the Digital green certificate - Union citizens & third countries - The accessibility and affordability of Covid-testing: MEPs debate part 2/3

Descrizione

Tag

Ricevi aggiornamenti su questo argomento

Descrizione

Tag

Ulteriori informazioni

Ricevi aggiornamenti su questo argomento